1. Home
  2. NEU vs BLCO Comparison

NEU vs BLCO Comparison

Compare NEU & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NewMarket Corp

NEU

NewMarket Corp

HOLD

Current Price

$628.02

Market Cap

5.6B

Sector

Industrials

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$15.88

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEU
BLCO
Founded
1887
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
Major Chemicals
Ophthalmic Goods
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
6.0B
IPO Year
2004
2022

Fundamental Metrics

Financial Performance
Metric
NEU
BLCO
Price
$628.02
$15.88
Analyst Decision
Buy
Analyst Count
0
12
Target Price
N/A
$18.55
AVG Volume (30 Days)
132.8K
386.0K
Earning Date
04-22-2026
04-29-2026
Dividend Yield
1.93%
N/A
EPS Growth
N/A
N/A
EPS
44.44
N/A
Revenue
$2,725,169,000.00
$5,101,000,000.00
Revenue This Year
N/A
$8.63
Revenue Next Year
N/A
$5.58
P/E Ratio
$13.99
N/A
Revenue Growth
N/A
6.47
52 Week Low
$510.07
$10.45
52 Week High
$875.97
$18.92

Technical Indicators

Market Signals
Indicator
NEU
BLCO
Relative Strength Index (RSI) 50.74 38.57
Support Level $582.93 $14.39
Resistance Level $646.28 $17.66
Average True Range (ATR) 19.92 0.49
MACD 3.75 -0.12
Stochastic Oscillator 73.71 19.62

Price Performance

Historical Comparison
NEU
BLCO

About NEU NewMarket Corp

NewMarket Corp is a holding company that, through its subsidiaries, manufactures and sells petroleum additives used in lubricating oils and fuels to enhance performance. The company operates through two segments: petroleum additives, mainly represented by Afton, where lubricant additives improve the efficiency and durability of base fluids and fuel additives help meet fuel specifications and improve fuel performance, and specialty materials, represented by AMPAC and Calca, including the antiknock compounds business of Ethyl, where primary raw materials include electricity, sodium chlorate, ammonia, chlorine, caustic, and hydrochloric acid, with graphite used in electrolytic cells. The company has operations in North America, Latin America, Asia Pacific, and EMEAI regions.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: